Synthesis and structure-activity relationships of novel arylalkyl 4-benzyl piperazine derivatives as sigma site selective ligands. 2000

S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
Laboratoire de chimie pharmaceutique, faculté de pharmacie, 35, chemin des Maraîchers, 31062, Toulouse, France.

Continuing our previous work that established that some chromones substituted by an aryl alkyl piperazino alkyl side chain are potent and selective sigma ligands and could be interesting in the treatment of psychosis, we synthesized 60 new compounds, replacing the chromone moiety by various cyclic systems. Many derivatives bind to the sigma sites in the nanomolar range and are generally selective in comparison with 5HT(1A) and the D(2) receptors. One of the most potent ligands of these series, 1-(2-naphthyl methyl)-4-benzyl piperazine 29, has been studied in various pharmacological tests. Although it doesn't have potential in the treatment of psychosis, the results we obtained confirm the data which indicates that such derivatives could be interesting in the treatment of inflammatory diseases.

UI MeSH Term Description Entries
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016202 N-Methylaspartate An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA). N-Methyl-D-aspartate,NMDA,N-Methyl-D-aspartic Acid,Acid, N-Methyl-D-aspartic,N Methyl D aspartate,N Methyl D aspartic Acid,N Methylaspartate
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
August 2010, Journal of medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
January 2005, Journal of medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
June 2002, Journal of medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
December 2010, Bioorganic & medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
July 1987, Chemical & pharmaceutical bulletin,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
March 2002, Bioorganic & medicinal chemistry letters,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
March 1999, Journal of medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
June 2013, European journal of medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
March 2008, Bioorganic & medicinal chemistry,
S Younes, and Y Labssita, and G Baziard-Mouysset, and M Payard, and M Rettori, and P Renard, and B Pfeiffer, and D Caignard
October 1998, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!